Quantcast
Last updated on April 16, 2014 at 5:23 EDT

Latest Ebola Stories

2011-04-20 08:30:00

SAN DIEGO, April 20, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it is the subject of an ABC news story that can be accessed online at: http://www.10news.com/news/27605561/detail.html (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) About Aethlon Medical At Aethlon Medical, we create revolutionary devices to address infectious disease and...

2011-04-12 08:01:00

SAN DIEGO, April 12, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD) announced today that its wholly owned subsidiary Exosome Sciences, Inc. (ESI) has validated the ability of its Enzyme Linked Lectin Specific Assay (ELLSA) to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, breast, lymphoma, and colorectal. In July 2010, ESI disclosed that it filed a patent relating...

2011-04-01 09:57:00

SAN DIEGO, April 1, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that InvestorIdeas.com has released the second installment of an interview regarding emerging opportunities in the biodefense industry that was conducted with Aethlon CEO, Jim Joyce. The interview can be accessed online at: http://www.investorideas.com/CO/AEMD/news/2011/04011.asp (Photo:...

2011-02-15 06:30:00

SAN DIEGO, Feb. 15, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it will present at the Wall Street Analyst Forum 22nd Annual Investor Conference on Tuesday, March 1, 2011 at 9:05 A.M. (EST). Aethlon Medical's Chairman and CEO, James A. Joyce, will present a corporate overview and will meet with investors during a series of one-on-one breakout...

2011-01-19 23:49:27

Ebola, a virus that causes deadly hemorrhagic fever in humans, has no known cure or vaccine. But a new study by University of Illinois at Chicago scientists has uncovered a family of small molecules which appear to bind to the virus's outer protein coat and may inhibit its entry into human cells. The results are to be published in the Journal of Medicinal Chemistry and are now online. Previous studies have shown that small molecules can interfere with the Ebola infection process, says Duncan...

2010-11-22 19:34:19

Boston University researchers develop portable diagnostic device Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor, which is the size of a quarter and can detect viruses in a blood sample, could be used in developing nations, airports and other places where natural or man-made outbreaks could erupt. "By enabling ultra-portable and fast detection, our technology can directly impact the course...

2010-11-19 12:27:59

Understanding the evolution of life-threatening viruses like influenza, Ebola and dengue fever, could help us to minimize their impact. New research points the way to a fossil record of viruses that have insinuated themselves into the genomes of insects and other animals, providing clues about their evolutionary history. The findings, published online on November 18 in the open-access journal PLoS Genetics, could enable scientists to elucidate general principles in virus evolution from their...

2010-11-18 07:30:00

SAN DIEGO, Nov. 18, 2010 /PRNewswire/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it has released a report entitled: "A Platform to Address Bioterrorism." The report is available on the company's website at: http://www.aethlonmedical.com/knowledge-center/special-reports/ Or on SlideShare at:...

2010-10-21 09:17:00

BALTIMORE, Oct. 21 /PRNewswire/ -- Paragon Bioservices, a Baltimore-based CMO focused on the contract research, process development and manufacturing of biologics, announced today that it has been awarded a $4.99 million contract to assist the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID) in its vaccine development efforts. The USAMRIID project involves process development and scale-up production of VLP-type vaccines against Ebola Zaire, Ebola Sudan, and Marburg...

2010-10-21 07:18:00

SAN DIEGO, Oct. 21 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today it has established primary clinical endpoints and clarified efficacy assessments related to a study that will evaluate the use of the Aethlon Hemopurifier® in combination with standard of care (SOC) HCV drug therapy. As a result, Aethlon will now initiate the...


Latest Ebola Reference Libraries

Franquet's Epauletted Fruit Bat, Epomops franqueti
2012-08-14 08:12:01

Franquet's epauletted fruit bat (Epomops franqueti) is a megabat that is native to Africa. Its range extends from Angola and Zambia in the south to Sudan and the Ivory Coast. This range includes Angola, Cameroon, Republic of the Congo, Ghana, Rwanda, and Uganda, among other areas. It is thought that these bats may appear in Zambia as well. It prefers a habitat within tropical and subtropical mangrove, arid, and moist forests as well as in swamps and arid savannahs. Franquet’s epauletted...

Western Red Colobus, Procolobus badius
2012-06-21 13:40:23

The western red colobus (Procolobus badius) is an Old World monkey that is native to Africa. Its range includes the forests of Ghana to Senegal. It was previously though that this species held all other red colobuses, although it still holds three subspecies. In 1994, western red colobuses that were eaten by common chimpanzees and other species contracted Ebola from the infected individuals. The western red colobus has been given a conservation status of “Endangered” on the IUCN Red List....

0_99e0cdc2371acc110d3f6ea58dc5b0d31
2011-02-17 16:29:01

Marburg virus, or Marburg, is the standard name for the genus of viruses Marburgvirus which contains the species, Lake Victoria Marburgvirus. It causes Marburg Hemorrhagic Fever (MHF) which originated with primates. It originated in Africa and can infect humans and primates. It is in the same taxonomic family as Ebola and both are identical structurally although they elicit different antibodies. It was named after the location of the first outbreak in Marburg, Germany in 1967. The...

0_99e0cdc2371acc110d3f6ea58dc5b0d3
2011-01-11 13:37:27

Filoviridae family of viruses belongs to the order of Mononegavirales. Filoviruses cause hemorrhagic fever often with fatal bleeding and coagulating abnormalities. The name comes from the Latin word filum, which alludes to the thread-like appearance of virus particles. They are single stranded negative sense RNA viruses that target primates. The two genera are Ebola-Reston virus and Marburg virus. The family was discovered in 1967 when 31 people were infected with the Marburg virus in...

0_f5076ad7b81c4e24010ad385f6f428e2
2011-01-11 10:59:51

Ebolavirus (EBOV), a viral genus, is the disease Ebola hemorrhagic fever (EHF), a viral hemorrhagic fever (VHF). The virus gets its name from the Ebola River Valley in the Democratic Republic of the Congo where the first outbreak occurred in 1976. The virus was obscure until 1989 when several widely publicized outbreaks occurred among monkeys in the United States. The virus disrupts the endothelial cells lining the interior surface of blood vessels. The platelets become unable to...

More Articles (5 articles) »